Cargando…

A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer

BACKGROUND: An amphiphilic cationic copolymer cholesterol-g-poly(amine-co-ester), namely Chol-g-PMSC-PPDL synthesized in a chemoenzymatic route has been utilized as a carrier for p53 gene delivery to check its antitumor efficacy, using human prostate cancer cell line PC-3 (p53 null) as a model. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Mengmeng, Chen, Jiawen, Zhang, Jiayuan, Liang, Xiao, Yang, Jiebing, Li, Dan, Li, Quanshun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391147/
https://www.ncbi.nlm.nih.gov/pubmed/30863051
http://dx.doi.org/10.2147/IJN.S191905
_version_ 1783398259010568192
author Dong, Mengmeng
Chen, Jiawen
Zhang, Jiayuan
Liang, Xiao
Yang, Jiebing
Li, Dan
Li, Quanshun
author_facet Dong, Mengmeng
Chen, Jiawen
Zhang, Jiayuan
Liang, Xiao
Yang, Jiebing
Li, Dan
Li, Quanshun
author_sort Dong, Mengmeng
collection PubMed
description BACKGROUND: An amphiphilic cationic copolymer cholesterol-g-poly(amine-co-ester), namely Chol-g-PMSC-PPDL synthesized in a chemoenzymatic route has been utilized as a carrier for p53 gene delivery to check its antitumor efficacy, using human prostate cancer cell line PC-3 (p53 null) as a model. MATERIALS AND METHODS: The transfection efficiency was measured by quantitative PCR and Western blotting assay. The anti-proliferative effect was detected using MTT method, colony formation assay and Live/Dead staining. The anti-migration effect was evaluated through wound healing and Transwell migration assays. RESULTS: The transfection efficiency assay indicated that the carrier-mediated p53 gene transfection could dramatically enhance the intracellular p53 expression level. Through p53 gene delivery, obvious anti-proliferative effect could be detected which was elucidated to be associated with the simultaneous activation of mitochondrial-dependent apoptosis pathway and cell cycle arrest at G1 phase. Meanwhile, the anti-migration effect could be obtained after p53 gene transfection. CONCLUSION: Chol-g-PMSC-PPDL-mediated p53 gene transfection could potentially be employed as a promising strategy for achieving effective anti-tumor response.
format Online
Article
Text
id pubmed-6391147
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-63911472019-03-12 A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer Dong, Mengmeng Chen, Jiawen Zhang, Jiayuan Liang, Xiao Yang, Jiebing Li, Dan Li, Quanshun Int J Nanomedicine Original Research BACKGROUND: An amphiphilic cationic copolymer cholesterol-g-poly(amine-co-ester), namely Chol-g-PMSC-PPDL synthesized in a chemoenzymatic route has been utilized as a carrier for p53 gene delivery to check its antitumor efficacy, using human prostate cancer cell line PC-3 (p53 null) as a model. MATERIALS AND METHODS: The transfection efficiency was measured by quantitative PCR and Western blotting assay. The anti-proliferative effect was detected using MTT method, colony formation assay and Live/Dead staining. The anti-migration effect was evaluated through wound healing and Transwell migration assays. RESULTS: The transfection efficiency assay indicated that the carrier-mediated p53 gene transfection could dramatically enhance the intracellular p53 expression level. Through p53 gene delivery, obvious anti-proliferative effect could be detected which was elucidated to be associated with the simultaneous activation of mitochondrial-dependent apoptosis pathway and cell cycle arrest at G1 phase. Meanwhile, the anti-migration effect could be obtained after p53 gene transfection. CONCLUSION: Chol-g-PMSC-PPDL-mediated p53 gene transfection could potentially be employed as a promising strategy for achieving effective anti-tumor response. Dove Medical Press 2019-02-13 /pmc/articles/PMC6391147/ /pubmed/30863051 http://dx.doi.org/10.2147/IJN.S191905 Text en © 2019 Dong et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Dong, Mengmeng
Chen, Jiawen
Zhang, Jiayuan
Liang, Xiao
Yang, Jiebing
Li, Dan
Li, Quanshun
A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
title A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
title_full A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
title_fullStr A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
title_full_unstemmed A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
title_short A chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
title_sort chemoenzymatically synthesized cholesterol-g-poly(amine-co-ester)-mediated p53 gene delivery for achieving antitumor efficacy in prostate cancer
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391147/
https://www.ncbi.nlm.nih.gov/pubmed/30863051
http://dx.doi.org/10.2147/IJN.S191905
work_keys_str_mv AT dongmengmeng achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT chenjiawen achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT zhangjiayuan achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT liangxiao achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT yangjiebing achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT lidan achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT liquanshun achemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT dongmengmeng chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT chenjiawen chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT zhangjiayuan chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT liangxiao chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT yangjiebing chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT lidan chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer
AT liquanshun chemoenzymaticallysynthesizedcholesterolgpolyaminecoestermediatedp53genedeliveryforachievingantitumorefficacyinprostatecancer